Liquid Chromatography-Mass Spectrometry Liquid chromatography-mass spectrometry (LC-MS) is considered the gold standard for measuring direct oral anticoagulants (DOACs) due to its high specificity, sensitivity, selectivity, and reproducibility
GLP-1s can be taken alone or with other medications, including insulin, metformin, and SGLT-2 inhibitors
Important factors affecting GLP-1 market demand and take-up include: The need for better long-term data on the safety and efficacy of use for the designated indications The rapidly expanding list of potential new indications for the drugs, including chronic kidney disease, broader cardiovascular risk reduction, metabolic liver disease, and Alzheimer's disease The number of similar drugs in the development pipeline Price point versus competition, which affects affordability and insurance coverage Marketing efforts of the manufacturers, supply and distribution constraints
Changes in the transit time of food and nutrients through the digestive tract can alter the conditions for various microbial species, potentially leading to shifts in the gut flora
